How can germline mutations distinguish risk for lethal and indolent prostate cancer?
Rong Na, MD, from the Huashan Hospital, Fudan University, Shanghai, China discusses germline mutations in prostate cancer at the European Association of Urology (EAU) conference 2017 in London, UK. He...
Author: VJOncology
Added: 04/19/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Conferences | Hospitals | Prostate Cancer | Urology & Nephrology